Volume 13 Supplement 1

Challenges in malaria research: Core science and innovation

Open Access

Characterization of specimens for quality control of malaria rapid diagnostic tests: what is the best indicator for performance?

  • Roxanne Rees-Channer1,
  • Jane Cunningham2,
  • Peter Chiodini1,
  • John Barnwell3,
  • Jeffery Glenn3,
  • Iveth Gonzalez4,
  • David Bell5 and
  • Sandra Incardona4
Malaria Journal201413(Suppl 1):P76

https://doi.org/10.1186/1475-2875-13-S1-P76

Published: 22 September 2014

Malaria rapid diagnostic tests (RDTs) are now considered an acceptable alternative for parasite based diagnosis in the absence of adequate quality microscopy. Selection of the most appropriate RDT among the sheer number of tests available commercially has long been a challenge, raising the need to objectively assess and compare test performance. In order to facilitate RDT procurement and stimulate improvement of the quality of RDTs, methods were developed for the collection and characterization of geographically diverse, malaria infected clinical blood specimens to set up a specimen bank for the evaluation of malaria RDTs, as part of the WHO Malaria RDT Product Testing programme. Parasite positive samples were diluted to low (200 p/ul) and higher (2000 p/ul) parasite densities and used to provide comparative data on the performance of RDT lots submitted by manufacturers. Only samples containing a single species and producing consistent antigen quantification results were eligible for inclusion in the WHO Malaria Specimen Bank. At both 200 and 2000 p/μl, a large variation in antigen concentrations was found, especially for P. falciparum HRP2, and to a lesser extent for pLDH and aldolase (both in P. falciparum and P. vivax samples); a trait that was independent of geographical origin. Possible reasons for this include the duration of infection at the time of blood collection and principally, differences in antigen expression between different isolates and stages of parasites. It is critical that performance evaluation panels are standardised at a parasite density being not only clinically relevant but also being close to the test detection limit to detect differences in test performance. Given the significant fluctuation in antigen concentrations at a given parasitaemia, appropriate sample sizes are required to cover that range and challenge the RDTs at the low end of this range of antigen concentrations. Antigen concentrations that are relevant for improvements in target sensitivity for RDTs are still to be determined for samples with parasite densities below 200 p/μl.

Authors’ Affiliations

(1)
Hospital for Tropical Diseases
(2)
GMP World Health Organisation
(3)
Center for Disease Control and Prevention
(4)
Foundation for Innovative New Diagnostics
(5)
Greater Good/Intellectual Ventures Lab

Copyright

© Rees-Channer et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement